Annual Drug Patent Expirations for JATENZO
Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has twenty-four patent family members in nine countries.
The generic ingredient in JATENZO is testosterone undecanoate. One supplier is listed for this compound. Additional details are available on the testosterone undecanoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com